81313 Pca3/klk3 antigen
Also known as: PCA3 urine test, PSA gene expression test
Prostate Cancer Antigen 3 (PCA3) and Kallikrein-Related Peptidase 3 (KLK3) antigen expression analysis in urine for prostate cancer risk assessment.
In Plain Language
Prostate cancer risk test; Urine-based prostate cancer screening
Clinical Context
Detects elevated PCA3 and PSA gene expression in urine to improve specificity of prostate cancer detection and predict treatment response.
RVU Information
CPT 81313 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81313?
CPT 81313 (Pca3/klk3 antigen) is a Pathology & Lab code. Prostate Cancer Antigen 3 (PCA3) and Kallikrein-Related Peptidase 3 (KLK3) antigen expression analysis in urine for prostate cancer risk assessment.
Who uses CPT code 81313?
CPT 81313 is used by Pathology, Urology, Oncology. Detects elevated PCA3 and PSA gene expression in urine to improve specificity of prostate cancer detection and predict treatment response.
When is CPT 81313 used?
Detects elevated PCA3 and PSA gene expression in urine to improve specificity of prostate cancer detection and predict treatment response.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.